Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-009038

CEO and Chairman sold 22,240 shares at an average $31.24 ($694,778)

  • CEO and Chairman acquired 22,240 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS CHAD M CEO and Chairman 2020-02-11 Option exercise +11,120 $0.33 $3,670 1,889,300 D: show line 1 in the form
ROBINS CHAD M CEO and Chairman 2020-02-11 Sale −11,120 $31.18 $346,722 1,878,180 D: show line 2 in the form
ROBINS CHAD M CEO and Chairman 2020-02-12 Option exercise +11,120 $0.33 $3,670 1,889,300 D: show line 3 in the form
ROBINS CHAD M CEO and Chairman 2020-02-12 Sale −11,120 $31.30 $348,056 1,878,180 D: show line 4 in the form
Open-market sales · 22,240 sh · avg $31.24 · $694,778

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
ROBINS CHAD M CEO and Chairman 2020-02-11 Option exercise · Stock Option (Right to Buy) −11,120 735,200 D: show line 5 in the form
ROBINS CHAD M CEO and Chairman 2020-02-12 Option exercise · Stock Option (Right to Buy) −11,120 724,000 D: show line 6 in the form
Loading xslF345X03/doc4.xml…